It is mind boggling what a rationalization of the patent process could achieve (and how many lawyers would be left unemployed).
Especially in pharmaceuticals. The egregious cost of some of these sparsely used drugs is entirely a function of the short period of time between drug approval and patent expiration. The pharma has to recoup all their costs and turn a profit in a very short period of time before the drug goes generic.
I have a (very) small business — that I will NOT grow, for the simple fact that adding employees exponentially increases the risk and burden on me, with only marginal increases in income.
It’s almost like there is a learning disability when you try to explain this to them. They seem to assume that for a small business, revenues and expenses always grow in a straight line relationship. Not always true. And they almost never consider capital-at-risk; it’s just assumed that the small businessperson will ignore risk and blindly turn that capital back into the business.